SGMS2 and central nervous system cancer: Indeed, an inverse correlation between SMS1 and SMS2 expression was observed when their mRNA levels were analyzed in 386 glioma patients (p < 0.0001; Figure 4E), thus further supporting the clinical relevance of the SMS1/SMS2 ratio in glioma progression and prognosis.